Literature DB >> 24905431

Regulation of NucB2/Nesfatin-1 throughout rat pregnancy.

María F Garcés1, Natalia E Poveda1, Elizabeth Sanchez1, Ángel Y Sánchez2, Susana B Bravo3, María J Vázquez4, Carlos Diéguez5, Rubén Nogueiras5, Jorge E Caminos6.   

Abstract

Nesfatin-1 is an anorexigenic neuropeptide derived by post-translational cleavage from the N-terminus region DNA binding/EF-hand/acidic amino acid rich region (NEFA)/nucleobindin2 (NucB2) protein through proteolytic prohormone convertases. This neuropeptide was originally localized in different appetite controlling areas such as the hypothalamic paraventricular nucleus, arcuate nucleus, supraoptic nucleus, lateral hypothalamic area, and nucleus tractus solitarius. The objective of this study was to determine the expression and the changes that occur to mRNA and protein of NucB2 and Nesfatin-1 serum levels during gestation. This study utilized molecular and immunological approaches to investigate the expression and regulation of NucB2/Nesfatin-1 protein throughout gestation in rat fed under ad libitum and food restricted conditions (30% nutrient restriction). NucB2 was immunolocalized in the amnion and decidua of the rat placenta. Nesfatin-1 serum levels were measured by radioimmunoassay on gestational days 12, 16, 19 and 21, showing a significant (p<0.01) decrease in serum levels after day 12 until the end of gestation in rats fed ad libitum. These results were correlated with the analysis of NucB2 mRNA, with a significant (p<0.01) reduction observed in both the mRNA and protein of NucB2 during the gestational days 12, 16 and 21. It was also observed that food restriction decreases Nesfatin-1 serum levels and NucB2 placental expression at day 16 of gestation when compared to pregnant rats fed ad libitum. This study illustrates for the first time through molecular and immunological approaches the NucB2 expression and regulation on rat placenta and that this peptide is regulated throughout pregnancy. Consistent with previous reports, our results provide additional evidence supporting the role of NucB2 protein as an anorexigenic peptide that may contribute to the regulation of feeding behavior and energy homeostasis. NucB2/Nesfatin-1 might play an important metabolic role during pregnancy and fetal development and its energy balance mediating role should be studied in various physiological and pathological conditions throughout gestation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nesfatin-1; Nucleobindin2 (NucB2); Placenta; Pregnancy

Mesh:

Substances:

Year:  2014        PMID: 24905431     DOI: 10.1016/j.physbeh.2014.05.042

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  5 in total

1.  Serum Cytokine Levels are related to Nesfatin-1/NUCB2 Expression in the Implantation Sites of Spontaneous Abortion Model of CBA/j × DBA/2 Mice.

Authors:  Yiwa Chung; Heejeong Kim; Sojeong Seon; Hyunwon Yang
Journal:  Dev Reprod       Date:  2017-03-31

Review 2.  The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

3.  Nesfatin-1 alleviates high glucose/high lipid-induced injury of trophoblast cells during gestational diabetes mellitus.

Authors:  Huanling He; Yingyu Liu; Minghe Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Th 17 Cells and Nesfatin-1 are associated with Spontaneous Abortion in the CBA/j × DBA/2 Mouse Model.

Authors:  Yiwa Chung; Heejeong Kim; Eunji Im; Philjae Kim; Hyunwon Yang
Journal:  Dev Reprod       Date:  2015-12

5.  Does nesfatin-1 influence the hypothalamic-pituitary-gonadal axis in adult males with obstructive sleep apnoea?

Authors:  Halina Batura-Gabryel; Barbara Bromińska; Nadia Sawicka-Gutaj; Ewa Cyrańska-Chyrek; Barbara Kuźnar-Kamińska; Hanna Winiarska; Magdalena Kostrzewska; Ariadna Zybek-Kocik; Aleksandra Hernik; Elżbieta Wrotkowska; Lena Bielawska; Szczepan Cofta; Marek Ruchała
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.